Medulloblastoma Clinical Trials
The newest version of Trial Finder is live!
What you see below is just a preview of what is available within the Trial Finder system! New features include:
- Customized daily email notifications about the trials you care about
- Search trials by keywords or local to your area
- Favorite specific trials
- Saved searches
- And more!
Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
Last Updated: 2024-01-26
Originally Posted: 2024-01-26
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
Last Updated: 2023-11-28
Originally Posted: 2022-02-09
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Last Updated: 2023-11-21
Originally Posted: 2016-03-31
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Last Updated: 2023-11-21
Originally Posted: 2022-05-19
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Last Updated: 2023-11-21
Originally Posted: 2021-11-03
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Last Updated: 2023-11-08
Originally Posted: 2022-09-10
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
Last Updated: 2023-10-30
Originally Posted: 2020-03-25
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Last Updated: 2023-10-30
Originally Posted: 2017-07-11
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Last Updated: 2023-10-30
Originally Posted: 2017-05-16
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Last Updated: 2023-10-23
Originally Posted: 2017-07-11
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
Last Updated: 2023-10-23
Originally Posted: 2020-02-26
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
Last Updated: 2023-10-23
Originally Posted: 2019-12-12
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Last Updated: 2023-10-23
Originally Posted: 2022-06-23
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Last Updated: 2023-09-28
Originally Posted: 2021-01-06
Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
Last Updated: 2023-09-21
Originally Posted: 2017-06-02
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Last Updated: 2023-08-31
Originally Posted: 2021-02-08
Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study
Last Updated: 2023-08-21
Originally Posted: 2021-11-22
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
Last Updated: 2023-08-14
Originally Posted: 2020-05-26
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Last Updated: 2023-08-14
Originally Posted: 2020-04-07
Study of Stored Tumor Samples in Young Patients With Brain Tumors
Last Updated: 2023-08-02
Originally Posted: 2009-05-12
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Last Updated: 2023-08-01
Originally Posted: 2019-04-11
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
Last Updated: 2023-07-27
Originally Posted: 2019-05-03
Rare Embryonal Tumors of the Central Nervous System: International Registry
Last Updated: 2023-07-21
Originally Posted: 2023-02-03
Feasibility and Acceptability of Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma
Last Updated: 2023-07-13
Originally Posted: 2023-03-06
Methionine PET/CT Studies In Patients With Cancer
Last Updated: 2023-07-06
Originally Posted: 2009-02-10
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Last Updated: 2023-07-05
Originally Posted: 2022-01-20
Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors
Last Updated: 2023-06-22
Originally Posted: 2016-09-19
Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults With Recurrent Medulloblastoma
Last Updated: 2023-06-22
Originally Posted: 2020-03-19
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
Last Updated: 2023-06-06
Originally Posted: 2016-08-23
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Last Updated: 2023-04-28
Originally Posted: 2019-04-05
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT
Last Updated: 2023-04-21
Originally Posted: 2011-05-19
Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Last Updated: 2023-04-19
Originally Posted: 2020-08-06
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Last Updated: 2023-04-05
Originally Posted: 2012-01-06
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
Last Updated: 2023-03-13
Originally Posted: 2020-12-10
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Last Updated: 2023-03-01
Originally Posted: 2019-09-09
DOTATOC PET/CT for Imaging NET Patients
Last Updated: 2023-02-21
Originally Posted: 2018-07-11
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma
Last Updated: 2023-02-08
Originally Posted: 2021-09-27
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Last Updated: 2023-01-05
Originally Posted: 2023-01-05
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Last Updated: 2022-12-20
Originally Posted: 2015-10-14
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Last Updated: 2022-12-19
Originally Posted: 2018-04-18
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.
Last Updated: 2022-10-24
Originally Posted: 2020-07-17
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Last Updated: 2021-11-23
Originally Posted: 2021-11-23
Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection
Last Updated: 2021-11-18
Originally Posted: 2021-11-18
Memory Neuroimaging in Children, Adolescents and Young Adults Following Pediatric Cancer
Last Updated: 2021-05-03
Originally Posted: 2020-03-27